A speech to the EU Parliament by Dr. David E. Martin, the content is reproduced below in German, below as a video in the original audio with German subtitles.
The corona virus did not see the light of day in 2019 or 2020, but as early as 1965, when it was first isolated as a model pathogen in connection with a cold. A pathogen that could be used and modified for various purposes. The first corona virus model was used in the USA in 1966 as a transatlantic biological experiment (data exchange between the USA and Great Britain) to manipulate humans. The first experiments with modified corona viruses were carried out on humans in 1967.
Between 1975 and 1977, research was carried out into how the corona virus could be implanted into animals such as pigs and dogs. It was only in 1990 that it was discovered that the corona virus in dogs and pigs had become an industrial problem for each specific industry. Breeders found that the virus caused gastrointestinal problems
Pfizer filed the first patent for a spike protein vaccine in 1990. But the vaccination failed due to the adaptability of the virus, just as flu viruses and many others mutate over time to maintain their species. All publications up to 2018 came to the conclusion that vaccines against the corona virus remain ineffective. This is also demonstrated by efforts by Ralph Baric and the University of North Carolina, Chapel Hill.
In 2002, this university patented an infectious clone with a replication defect. This means that this clone is genetically modified in such a way that it can infect target cells and introduce a transgene into them, but can no longer replicate in them. As a result, this infectious clone with a replication defect can be classified as a biological weapon. The research leading to this patent was funded by Anthony Fauci, NAID (National Institute of Allergy and Infectious Diseases) from 1999 to 2002. A year later, the patented SARS virus appeared, the severe acute respiratory syndrome, a flu-like infectious disease of the upper respiratory tract.
In April 2003, the CDC, Centers for Disease Control and Prevention in Georgia, Druid Hills, patented the isolated coronavirus, violating U.S. laws and the biological (and chemical) weapons treaties.
A virus sequence was downloaded from China and a patent was applied for in the USA. Since this constituted an act of crime, the patent office rejected the application twice. With appropriate financial support, the patent was granted in 2007.
The RT-PCR test, supposedly intended to identify the risks posed by the coronavirus, was identified as a bioterrorism threat at EU-sponsored events in 2002 and 2003.
In 2005, the above-mentioned pathogen clone was explicitly referred to as “bioterrorism” and “bioweapons platform technology”. From 2005 onwards it was officially classified as a “bioweapon precursor”.
Since 2005, Anthony Fauci's $10 billion has matched the balance sheet for bio-defense. There is a gain-of-function moratorium that should freeze all effort activities related to gain-of-function research. However, the University of North Carolina, Chapel Hill received. In the fall of 2014, they received a letter from the NAID stating that the moratorium did not apply and that they received an exception because their grants had already been funded.
In 2016 an article appeared that “The SARS corona virus will appear in humans”. The virus was named WIV1 – Wuhan Institute for Virology Virus 1.
In 2017 and 2018, the language was “There will be an accidental or intentional release of a respiratory pathogen.”
In April 2019, Moderna's patent applications were amended four times to include the language "accidental or intentional release of a respiratory pathogen" as justification for producing a vaccine for a non-existent disease.
This procedure is deliberate. In September 2019, the world was informed of the accidental or intentional release of a respiratory pathogen. In September 2020, this resulted in global acceptance of a universal vaccine template. The purpose of the corona virus was thus achieved.
.